Clinical Trial

Tolerability and Efficacy Study of Reinnerva/Lubristil+G vs Vismed

Completed
View on ClinicalTrials.gov →
Summary
The clinical investigation #1122 is a Post Market Clinical Follow Up Study on the EC marked medical device Reinnerva/Lubristil +G, sterile eye drops, compared to Vismed medical device, sterile eye drops, to demonstrate the clinical performance and tolerability of Reinnerva/Lubristil +G to stabilize the lacrimal film and improve the ocular surface condition in the cases of quali-quantitative alterations of the tear film .
Trial Details
NCT Number NCT07422259
Lead Sponsor Medivis SRL
Collaborators: University of Messina
Conditions Keratoconjunctivitis Sicca
Enrollment 40 participants
Start Date 2025-06-09
Primary Completion 2025-09-03 (estimated)
Study Completion 2025-09-03 (estimated)
Updated on ClinicalTrials.gov 2026-02-19